Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P374: Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factorsECCO '18 Vienna
Year: 2018
Authors:

G. Losurdo1*, A. Iannone2, M. Mangia3, E. Shahini2, F. Albano2, S.F. Rizzi2, R.F. La Fortezza2, R. Lovero2, A. Contaldo2, M. Barone2, G. Leandro4, E. Ierardi2, A. Di Leo2, M. Principi2

1University of Bari, Department of Emergency and Organ Transplantation, Bari, Italy, 2University of Bari, DETO, Bari, Italy, 3Azienda Ospedaliera Consorziale Policlinico, Bari, Italy, 4IRCCS Saverio de Bellis, Department of Gastroenterology and Digestive Endoscopy, Castellana Grotte, Italy

P375: Self-management in inflammatory bowel disease: A perspective of patients and caretakersECCO '18 Vienna
Year: 2018
Authors:

N. Peek-Kuijt*, S. van den Burg, A. van der Meulen- de Jong, J. Maljaars

Leiden University Medical Center, Gastroenterology, Leiden, The Netherlands

P376: Clinical effectiveness of vedolizumab in a tertiary care cohort of IBD patientsECCO '18 Vienna
Year: 2018
Authors:

S. Bots1*, E. van Baalen2, N. de Boer3, K. Gecse2, C. Ponsioen2, G. D'Haens2, M. Löwenberg2

1Academic Medical Centre (AMC), Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Academic Medical Center (AMC), Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands, 3VuMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

P377: Complications related to varicella zoster virus infection in patients with inflammatory bowel disease in the pre-JAK inhibitors era: A prospective studyECCO '18 Vienna
Year: 2018
Authors:

R. de Francisco1,2*, A. Castaño1, P. Flórez-Díez1, S. Martínez-González1, I. Pérez-Martínez1, N. Rodríguez-Ferreiro1, V. Jiménez-Beltrán1, A. Suárez1,2, S. Riestra1,2

1Hospital Universitario Central de Asturias, Gastroenterology, Oviedo, Spain, 2Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain

P378: Immunisation practices for hepatitis B and response to vaccination in Greek patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

D. Kalogera1*, S. Siakavellas1, E. Zambeli2, E. Tsironi3, M. Tzouvala4, D. Moschovis4, A. Kostas1, G. Axiaris2, E. Kourkoutas2, K. Filippakou3, J. Vlachogiannakos1, S. Michopoulos2, G. Papatheodoridis1, G. Bamias5

1National and Kapodistrian University of Athens, Laiko General Hospital, Academic Department of Gastroenterology, Athens, Greece, 2Alexandra Hospital, Gastroenterology Unit, Athens, Greece, 3Metaxa Memorial Cancer Hospital of Piraeus, Department of Gastroenterology, Athens, Greece, 4General Hospital of Nikea and Piraeus Agios Panteleimon, Department of Gastroenterology, Athens, Greece, 5on behalf of the Greek Vedolizumab Study group, Athens, Greece

P379: Infliximab or adalimumab: Which should be used first for Crohn’s disease? A multicentre retrospective observational studyECCO '18 Vienna
Year: 2018
Authors:

S. Takahashi1*, T. Inokuchi2, S. Hiraoka2, T. Toyokawa3, S. Takagi4, K. Takemoto5, J. Miyaike6, T. Fujimoto7, R. Higashi8, H. Yasuhara9, T. Nawa10, S. Suzuki11, J. Kato12, H. Okada2

1Kagawa Prefectural Central Hospital, Department of gastroenterology, Takamatsu, Japan, 2Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Gastroenterology and Hepatology, Okayama city, Japan, 3National Hospital Organization Fukuyama Medical center, Department of Gastoenterology, Fukuyama city, Japan, 4Japanese Red Cross Society Himeji Hospital, Department of Internal Medicine, Himeji city, Japan, 5Tsuyama chuo Hospital, Depatment of Gastroenterology, Tsuyama city, Japan, 6Saiseikai Imabari Hospital, Department of Internal medicine, Imabari city, Japan, 7Iwakuni medical center, Department of Gastroenterology, Iwakuni, Japan, 8Hiroshima City Hiroshima Citizens Hospital, Department of Gastroenterology, Hiroshima city, Japan, 9Mitoyo General Hospital, Department of Gastroenterology, Mitoyo City, Japan, 10Fukuyama City hospital, Department of gastroenterology, Fukuyama City, Japan, 11Sumitomo Besshi Hospital, Department of Internal medicine, Niihama city, Japan, 12Wakayama Medical University, Second Department of Internal Medicine, Wakayama City, Japan

P380: Risk factors for poor postoperative outcome in patients with Crohn’s disease undergoing ileocaecal resectionECCO '18 Vienna
Year: 2018
Authors:

A. Labidi1*, M. Ben Abbes1, S. Hamdi1, H. Maghrebi2, N. Ben Mustapha1, M. Fekih1, L. Zouiten1, M. Serghini1, Z. Ben Safta2, J. Boubaker1

1Rabta Hospital, Gastroenterology "A", Tunis, Tunisia, 2Rabta Hospital, Surgery "A", Tunis, Tunisia

P381: Predictors of vedolizumab response to induction: Real-life experienceECCO '18 Vienna
Year: 2018
Authors:

A. Gutiérrez1,2*, L. Sempere1, M. Belvis3, J.M. Vázquez4, R. Laveda5, M. García6, F. Argüelles-Arias3, H. Pallarés4, L. Castro3, E. Gómez4, B. Maldonado3

1Hospital General Universitario Alicante, Alicante, Spain, 2CIBERehd, Madrid, Spain, 3Hospital Universitario Virgen Macarena, Sevilla, Spain, 4Hospital Juan Ramón Jiménez, Huelva, Spain, 5Hospital San Juan, Alicante, Spain, 6Hospital General Universitario Elche, Elche, Spain

P382: CRP/albumin ratio: Predictive factor of the response to corticosteroids in acute severe colitisECCO '18 Vienna
Year: 2018
Authors:

S. Jardak1*, M. Medhioub2, K. Agar2, L. Hamzaoui1,2,3, A. Khsiba2, M.M. Azouz2

1Nabeul-Tunisia, Department of gastroenterology Nabeul-Tunisia, Nabeul, Tunisia, 2Nabeul-Tunisia, Nabeul-Tunisia, Nabeul, Tunisia, 3Mohamed Taher Maamouri Hospital, Department of Gastroenterology, Nabeul, Tunisia

P383: Breast feeding practices differ between mothers with IBD and mothers without IBDECCO '18 Vienna
Year: 2018
Authors:

C. Baker1, V. Nguyen2, S. Andriasak2, L. Ambrosio3, K.-A. Berga1, L. Dieleman3, B. Halloran3, K.I. Kroeker3, F. Peerani3, K. Wong3, V.W. Huang3*, R.N. Fedorak3

1Grant MacEwan, Edmonton, Canada, 2University of Alberta, Edmonton, Canada, 3University of Alberta, Gastroenterology, Edmonton, Canada

P384: Gari-leo prospective study on anti-TNF therapy in ulcerative colitis relapse patientsECCO '18 Vienna
Year: 2018
Authors:

S. Kato*, K. Kani, A. Ishibashi, M. Oka, S. Nagoshi, K. Yakabi

Saitama Medical Center, Saitama Medical University, Department of Gastroenterology and Hepatology, Kawagoe City, Saitama, Japan

P385: Colectomy-free survival and factors associated with it in children with ulcerative colitis managed in a tertiary IBD centre in the UKECCO '18 Vienna
Year: 2018
Authors:

S.-Y. Ong*, W. Haller, R. Muhammed

Birmingham Children's Hospital, Gastroenterology, Birmingham, UK

P386: Methotrexate use in combination with anti-TNFα agents in IBD: A tertiary centre experienceECCO '18 Vienna
Year: 2018
Authors:

W. Waddingham*, A. Nwaogu, E. Michael, L. Whitley, H. Parker, R. Kettle, I. Parisi, E. Seward, S. McCartney, S. Bloom, R. Vega, F. Rahman, S. Mehta

University College London Hospitals NHS Foundation Trust, Gastroenterology, London, UK

P387: Infliximab therapeutic drug monitoring test validated for measuring CT-P13 and SB2 biosimilarsECCO '18 Vienna
Year: 2018
Authors:

M.B. Ruiz-Agüello*, A. Maguregui, A. Martínez, D. Nagore

Progenika Biopharma SA, R&D Department, Derio, Spain

P388: Response to IV steroid therapy in acute severe ulcerative colitis (ASUC) is not altered by admission to a tertiary referral centre: The NHS Lothian experienceECCO '18 Vienna
Year: 2018
Authors:

T. Manship*, R. Grant, F. Jagger, R. Lynch, C. Lees, J. Satsangi, I. Arnott

Western General Hospital, Gastroenterology, Edinburgh, UK

P390: Methotrexate is not superior to placebo in maintaining remission in patients with ulcerative colitis: results from the MERIT-UC studyECCO '18 Vienna
Year: 2018
Authors:

H. Herfarth1*, E.L. Barnes1, S. Jackson1, J.F. Valentine2, J. Hanson3, P.D.R. Higgins4, K.L. Isaacs1, M.T. Osterman5, B.E. Sands6, J.D. Lewis5, MERIT-UC study group

1University of North Carolina, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, USA, 2University of Utah, Department of Medicine, Utah, USA, 3Carolinas Health Care, Medicine, Charlotte, USA, 4University of Michigan, Department of Internal Medicine, Department of Gastroenterology, Ann Arbor, USA, 5University of Pennsylvania School of Medicine, Department of Gastroenterology, Inflammatory Bowel Disease Center, Philadelphia, USA, 6Icahn School of Medicine at Mount Sinai, Department of Gastroenterology, New York City, USA

P391: The availability of anti-TNF agents is associated with reduced early surgical requirements in Crohn’s disease but not in ulcerative colitis. A nationwide study from the Eneida registryECCO '18 Vienna
Year: 2018
Authors:

M. Guasch1, A. Clos2, I. Ordás3,4, V. García-Sánchez5, J.P. Gisbert4,6, C. Taxonera7, I. Vera8, M. Mínguez9, J. Guardiola10, A. López-Sanromán11, M. Rivero-Tirado12, P. Nos13, F. Gomollón4,14, A.Y. Carbajo15, R. de Francisco16, M.D. Martín-Arranz17, E. Garcia-Planella18, S. García-López19, L. de Castro20, X. Calvet4,21, R. Camargo22, M. Esteve4,23, B. Sicilia24, M. Andreu25, A. Macho26, M. Piqueras27, F. Bermejo28, A. Gutiérrez29, D. Busquets30, P. Martínez-Montiel31, J. Hinojosa32, J.L. Pérez-Calle33, L. Bujanda34, A. Rodríguez-Pérez35, R. Lorente36, N. Jiménez37, M. Navarro-Llavat38, J.L. Cabriada39, P. Camo40, M. Van Domselaar41, E. Rodríguez-González42, C. Rodríguez-Gutiérrez43, J.M. Huguet44, A.J. Lucendo45, F. Argüelles46, P. Almela47, O. Merino48, M. Calafat49, M. Ogueta50, M. Charro51, J. Llaó52, C. Muñoz53, L. Ramos54, Á. Abad55, Ó. Roncero56, M. Barreiro-de-Acosta57, E. Sesé58, M. Mañosa2,4, E. Domènech2,4*

1Hospital San Jorge, Surgery, Huesca, Spain, 2Hospital Germans Trias i Pujol, Gastroenterology, Badalona, Spain, 3Hospital Clínic, Gastroenterology, Barcelona, Spain, 4CIBERehd, Madrid, Spain, 5Hospital Reina Sofía, Gastroenterology, Córdoba, Spain, 6Hospital de la Princesa, Gastroenterology, Madrid, Spain, 7Hospital Clínico San Carlos, Gastroenterology, Madrid, Spain, 8Hospital Universitario Puerta de Hierro, Gastroenterology, Madrid, Spain, 9Hospital Clínico de Valencia, Gastroenterology, Valencia, Spain, 10Hospital Universitari de Bellvitge, Gastroenterology, L'Hospitalet de Llobregat, Spain, 11Hospital Ramón y Cajal, Gastroenterology, Madrid, Spain, 12Hospital Marqués de Valdecilla, Gastroenterology, Santander, Spain, 13Hospital Politècnic La Fe, Gastroenterology, Valencia, Spain, 14Hospital Clínico Lozano Blesa, Gastroenterology, Zaragoza, Spain, 15Hospital Río Hortega, Gastroenterology, Valladolid, Spain, 16Hospital Universitario Central de Asturias, Gastroenterology, Ovideo, Spain, 17Hospital La Paz, Gastroenterology, Madrid, Spain, 18Hospital de la Santa Creu i Sant Pau, Gastroenterology, Barcelona, Spain, 19Hospital Universitario Miguel Servet, Gastroenterology, Zaragoza, Spain, 20Complejo Hospitalario Universitario de Vigo, Gastroenterology, Vigo, Spain, 21Hospital Parc Taulí, Gastroenterology, Sabadell, Spain, 22Hospital Clínico Virgen de la Victoria, Gastroenterology, Málaga, Spain, 23Mútua de Terrassa, Gastroenterology, Terrassa, Spain, 24Complejo Hospitalario Universitario de Burgos, Gastroenterology, Burgos, Spain, 25Hospital Parc del Mar, Gastroenterology, Barcelona, Spain, 26Hospital Clínico Universitario de Valladolid, Gastroenterology, Valladolid, Spain, 27Consorci Sanitari de Terrassa, Gastroenterology, Terrassa, Spain, 28Hospital Universitario Fuenlabrada, Gastroenterology, Fuenlabrada, Spain, 29Hospital General Universitario de Alicante, Gastroenterology, Alicante, Spain, 30Hospital Dr. Josep Trueta, Gastroenterology, Girona, Spain, 31Hospital 12 de Octubre, Gastroenterology, Madrid, Spain, 32Hospital de Manises, Gastroenterology, Manises, Spain, 33Hospital Universitario Fundación de Alcorcón, Gastroenterology, Alcorcón, Spain, 34Hospital de Donostia, Gastroenterology, Donostia, Spain, 35Hospital Universitario de Salamanca, Gastroenterology, Salamanca, Spain, 36Hospital General de Ciudad Real, Gastroenterology, Ciudad Real, Spain, 37Hospital General Universitario de Elche, Gastroenterology, Elche, Spain, 38Hospital Moisès Broggi, Gastroenterology, Sant Joan Despí, Spain, 39Hospital de Galdakao, Gastroenterology, Galdakao, Spain, 40Hospital San Jorge, Gastroenterology, Huesca, Spain, 41Hospital de Torrejón, Gastroenterology, Torrejón de Ardoz, Spain, 42Hospital Nuestra Señora de la Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain, 43Complejo Hospitalario de Navarra, Gastroenterology, Pamplona, Spain, 44Hospital General Universitario de Valencia, Gastroenterology, Valencia, Spain, 45Hospital General de Tomelloso, Gastroenterology, Tomelloso, Spain, 46Hospital Virgen de la Macarena, Gastroenterology, Sevilla, Spain, 47Hospital General de Castelló, Gastroenterology, Castelló, Spain, 48Hospital de Cruces, Gastroenterology, Barakaldo, Spain, 49Hospital Son Llàtzer, Gastroenterology, Mallorca, Spain, 50Hospital Universitario de Áraba, Gastroenterology, Vitoria, Spain, 51Hospital Royo Villanova, Gastroenterology, Zaragoza, Spain, 52Hospital Sant Joan de Déu - Althaia, Gastroenterology, Manresa, Spain, 53Hospital de Basurto, Gastroenterology, Basurto, Spain, 54Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain, 55Hospital de Viladecans, Gastroenterology, Viladecans, Spain, 56Hospital Mancha Centro, Gastroenterology, Alcázar de San Juan, Spain, 57Complejo Hospitalario Universitario de Santiago, Gastroenterology, Santiago de Compostela, Spain, 58Hospital Universitari Arnau de Vilanova, Gastroenterology, Lleida, Spain

P392: Comprehensive video capsule endoscopy-based monitoring predicts short and long-term risk of disease flares in small bowel Crohn’s disease: A prospective cohort studyECCO '18 Vienna
Year: 2018
Authors:

S. Ben-Horin1*, A. Lahat1, M.M. Amitai2, E. Klang2, D. Yablecovitch1, S. Neuman1, N. Levhar1, L. Selinger1, M. Bubis1, O. Picard1, D. Turner3, S. Odes4, H. Yanai5, Y. Chowers6, I. Dotan5, U. Kopylov1, R. Eliakim1

1Sheba Medical Center and Sackler School of Medicine, Gastroenterology, Tel Hashomer, Israel, 2Sheba Medical Center, Department of Radiology, Tel Hashomer, Israel, 3Sharei Zedek Medical Center, Department of Gastroenterology, Jerusalem, Israel, 4Ben-Gurion University of the Negev and Soroka Medical Center, Department of Gastroenterology, Beer-Sheva, Israel, 5Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, IBD Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel, 6Rambam Health Care Campus and Bruce Rappaport School of Medicine, Technion Institute of Technology, Department of Gastroenterology, Haifa, Israel

P393: Long-term prediction of infliximab response using CD-62L shedding assay: Longitudinal data from 5-year study in inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

J. Macpherson1, F. Bravo2, P. Andrew1, E. Slack1, N. Patuto1, J. Cahenzli1, K.D. McCoy1, A.J. Macpherson2, P. Juillerat1,2*

1University Bern, Maurice E Müller Laboratories, Universitätsklinik für Viszerale Chirurgie und Medizin, Inselspital, Bern, Switzerland, 2Clinic for Visceral Surgery and Medicine, Gastroenterology, Bern, Switzerland